Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R McLean

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Medicinal Chemistry|January 1, 1972
Inhibitors of platelet aggregation. 3. ((Dialkylamino)alkyl)thio heterocyclic compoundsR H Wheelock, E F Elslager, N F Haley, et al.
Journal of Medicinal Chemistry|May 1, 1971
Inhibitors of platelet aggregation. 1. 5,10-Dihydro-3-(phenyl, thienyl, and furyl)thiazolo(3,2-b)(2,4)benzodiazepines and related compoundsE F Elslager, J R McLean, S C Perricone, et al.
Journal of Medicinal Chemistry|September 1, 1971
Inhibitors of platelet aggregation. 2. 9-((Dialkylamino)alkyl)thio-3-(dimethylamino)acridines and related acridine derivativesE F Elslager, N F Haley, J R McLean, et al.
Therapeutic Drug Monitoring|January 1, 1986
Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapyL M Ojemann, R A Shastri, A J Wilensky, et al.
Bioelectromagnetics|January 1, 1991
Cancer promotion in a mouse-skin model by a 60-Hz magnetic field: II. Tumor development and immune responseJ R McLean, M A Stuchly, R E Mitchel, et al.
Oncogene|September 13, 2011
Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasisV Walia, Y Yu, D Cao, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Medicinal Chemistry|January 1, 1972
Inhibitors of platelet aggregation. 3. ((Dialkylamino)alkyl)thio heterocyclic compoundsR H Wheelock, E F Elslager, N F Haley, et al.
Journal of Medicinal Chemistry|May 1, 1971
Inhibitors of platelet aggregation. 1. 5,10-Dihydro-3-(phenyl, thienyl, and furyl)thiazolo(3,2-b)(2,4)benzodiazepines and related compoundsE F Elslager, J R McLean, S C Perricone, et al.
Journal of Medicinal Chemistry|September 1, 1971
Inhibitors of platelet aggregation. 2. 9-((Dialkylamino)alkyl)thio-3-(dimethylamino)acridines and related acridine derivativesE F Elslager, N F Haley, J R McLean, et al.
Therapeutic Drug Monitoring|January 1, 1986
Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapyL M Ojemann, R A Shastri, A J Wilensky, et al.
Bioelectromagnetics|January 1, 1991
Cancer promotion in a mouse-skin model by a 60-Hz magnetic field: II. Tumor development and immune responseJ R McLean, M A Stuchly, R E Mitchel, et al.
Oncogene|September 13, 2011
Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasisV Walia, Y Yu, D Cao, et al.
Pageof 6